- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IB Non-Small Cell Lung Carcinoma in New Zealand
Total 2021 results
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedNon-Small-Cell Lung CarcinomaUnited States, China, Taiwan, Spain, Korea, Republic of, France, Canada, Hong Kong, Japan, Singapore
-
Eisai Inc.Quintiles, Inc.CompletedNon Small Cell Lung CancerUkraine, Germany, United States, Italy, Czechia
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
NYU Langone HealthRecruitingNSCLC Stage IVUnited States
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Genomic Health®, Inc.TerminatedNon Small Cell Lung CarcinomaUnited States, Spain, Chile, France, Ireland, Japan, United Kingdom
-
Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Wake Forest University Health SciencesCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
PfizerTerminatedCarcinoma, Non-Small Cell LungUnited States, Germany, Italy
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States, Canada
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZeneca UK LimitedRecruitingBreast Cancer | Non-small Cell Lung CarcinomaUnited States, Spain, France, United Kingdom
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Canada, France, Singapore, Taiwan
-
Hi-Q Marine Biotech International, Ltd.WithdrawnNSCLC Stage IV | NSCLC, Stage IIITaiwan
-
Regeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Israel
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
Blueprint Medicines CorporationAnalysis Group, Inc.Enrolling by invitationNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Carcinoma | Neoplasms, Germ Cell and Embryonal | Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung | Bronchial Diseases | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Neoplasms... and other conditionsUnited States, France, Switzerland
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, United Kingdom, Australia, Belgium, Brazil, Canada, China, Portugal, Spain, France, Germany, Poland, Hong Kong, Israel, Thailand, Turkey, Japan, Austria, Hungary, Italy, Taiwan, Netherlands, Greece, New... and more
-
Catherine ShuCompleted
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Achieve Life SciencesCompletedNon-small Cell Lung CancerUnited States, Canada
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Heather WakeleeEli Lilly and Company; Genentech, Inc.CompletedNeoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Heat BiologicsCompletedNon-small Cell Lung CancerUnited States
-
GlobeImmuneMemorial Sloan Kettering Cancer CenterCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Genentech, Inc.CompletedNon-Small-Cell Lung Carcinoma | Neoplasm Recurrence, LocalUnited States
-
Peter Bushunow MDNovartis PharmaceuticalsTerminatedNon Small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedRadiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung CancerLung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Small Cell Lung CancerUnited States
-
Celgene CorporationCompletedNon-Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); American College of RadiologyCompleted
-
National Cancer Institute (NCI)RecruitingLung Adenocarcinoma | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Lung Adenosquamous CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisRecruiting
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
GlaxoSmithKlineTerminated
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; United States Department of DefenseCompleted
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
Roswell Park Cancer InstituteCompleted
-
National Cancer Institute (NCI)CompletedExtensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, United States, Belgium, France, Italy, Netherlands, United Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Small Cell Lung CancerUnited States
-
University of PittsburghBristol-Myers SquibbCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
Cadila PharnmaceuticalsCompletedNon Small Cell Lung CancerIndia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung CancerSpain, Italy, Poland, Brazil, Turkey, Serbia, France, Korea, Republic of, Romania, Hungary, Russian Federation, United States, United Kingdom, Germany, Greece, Japan, Thailand, Ukraine, China